Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion type Assertion NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_head.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion description "[Overexpression of human EGF receptor HER-2 (erbB2) leads to amplified heregulin (HRG) signaling, promoting more aggressive breast cancer that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion evidence source_evidence_literature NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion SIO_000772 14603258 NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion wasDerivedFrom befree-2016 NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion wasGeneratedBy ECO_0000203 NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.